Nyheder

18th World Stroke Congress (WSC 2026) | October 21 – 23, 2026 | Seoul, Korea

18th World Stroke Congress (WSC 2026) | October 21 – 23, 2026 | Seoul, Korea

Set against the dynamic backdrop of Seoul, WSC 2026, the 18th World Stroke Congress, will bring together leading stroke professionals, researchers, members of stroke support organizations, and policymakers to advance stroke care and research.

This year’s congress marks an exciting milestone: WSC 2026 will be held as a joint meeting with the International Conference Stroke Update, in collaboration with the Korean Stroke Society. This integrated scientific event will bring together global and regional expertise, creating a powerful platform for knowledge exchange and collaboration across the full spectrum of stroke research and care.

The program will showcase groundbreaking new science, late-breaking clinical trials, and critical discussions on the latest advancements in stroke prevention, treatment, and rehabilitation. With a strong emphasis on global collaboration, advocacy, diversity, equity, and inclusion, WSC 2026 is a key platform for driving progress in stroke care worldwide. Attendees will have the opportunity to engage in insightful discussions, gain valuable knowledge, and connect with experts in the field. Notably, there is a dedicated emphasis on supporting early career investigators, providing them with extensive pathways for professional growth.

Strengthening “One World Voice for Stroke” by bringing the global community together, we can shape a better future.

Register now and join us in Seoul: https://worldstrokecongress.org/register/

Partner with WNPC27 as a Supporting Society

On behalf of the Organizing Committee, we are delighted to extend a warm invitation to your esteemed society to collaborate with and participate in the World Neuroscience & Psychiatry Conference 2027 <https://neuroscience.episirus.org/bangkok/>  (WNPC27), a premier international platform dedicated to advancing neuroscience, psychiatry, brain health, mental healthcare, and interdisciplinary innovations.

Conference Details:
Event: World Neuroscience & Psychiatry Conference 2027 (WNPC27)
Date: March 05-06, 2027
Location: Bangkok, Thailand

The conference will bring together distinguished neuroscientists, psychiatrists, researchers, academicians, clinicians and industry leaders from around the world to exchange knowledge, share groundbreaking research, and foster meaningful collaborations that contribute to advancing neuroscience, psychiatry, mental health, and neurological care globally.

The scientific program will feature keynote presentations, oral and poster sessions, panel discussions, workshops, and networking opportunities focused on the latest developments in neuroscience & psychiatry.

As a valued society, we are pleased to offer:
* One Complimentary Speaker Slot for a nominee from your society, including a Full Registration Fee Waiver
To nominate a speaker, kindly share:
* A short biography (100-150 words)
* Presentation title/topic
To facilitate planning and scientific program development, we would greatly appreciate receiving your expression of interest and speaker nomination by 10 August 2026.

We kindly encourage you to circulate this opportunity among your members and consider becoming an active part of this important international gathering.

We are confident that participation in WNPC27 will provide significant value through professional development, scientific exchange, international networking, and collaborative opportunities within the global neuroscience and psychiatry communities.

Should you require any additional information or assistance, please do not hesitate to contact our organizing team at neuromeet@episirus.org <mailto:neuromeet@episirus.org>  . We would be pleased to assist you.

We look forward to the opportunity of welcoming your society and its members to Bangkok, Thailand, for a successful and inspiring conference.

Thank you for your time and consideration.

With warm regards,
Ileana Zen
Program Coordinator
WNPC27

Office Address:
1521 Concord Pike Ste 301 #246
Wilmington, DE 19803, USA
Contact: +1 302 440 1610
[Unsubscribe link <https://a720d041.sibforms.com/serve/MUIFAJJuQDfrq2yvshfl3umL7DwkXVMx0hvxzIlJwSd12kD3rmu59Y5DEjGkOvLYVijTcIaso3XO5ykyv4mlW39Gqit0hhHvt4uI1BOflWwOC-vbjY52uRInwa87NRZvRmt2uOAQlO1mtl2MQogRe3tgOkvaeGKpo0kcvkmDUe57b59ToJ3Hxwev3lKNqRaGEDEK5GJmnxACysFz

68th Annual Meeting of the Japanese Society of Neurology

On behalf of the organizing committee, we are pleased to inform you that the 68th Annual Meeting of the Japanese Society of Neurology (JSN Annual Meeting) will be held from May 19 to 22, 2027 in Niigata, Japan.

Please find attached the 1st announcement for the 68th JSN Annual Meeting.

68_JSN_meeting_2027

Official Website of the 68th Annual Meeting of the JSN

<https://www.neurology-jp.org/neuro2027/en/

If you should have any questions, please feel free to contact us.

Your kind support and cooperation would be greatly appreciated.

Sincerely yours,

Osamu Onodera, M.D., Ph.D.

Congress President

The 68th Annual Meeting of the Japanese Society of Neurology

Nye medlemmer til Kræftens Bekæmpelses Videnskabelige Udvalg

Kræftens Bekæmpelses Videnskabelige Udvalg – Biologi & Klinik (KBVU-BK) og Menneske & Samfund (KBVU-MS) søger nye medlemmer pr. 1. januar 2027.

Call for proposals for new members for the scientific committees from 2027

Indstillingsfrist 20. august 2026 kl. 12:00.

Vedlagt er opslaget, som I bedes videresende til rette vedkommende. Hvis muligt, må I også meget gerne bringe opslaget via jeres øvrige nyhedskanaler.

Opslaget kan desuden findes på vores hjemmeside under Aktuelle opslag – Kræftens Bekæmpelses Videnskabelige Udvalg

På forhånd tak.

Læs om den forskning Kræftens Bekæmpelse har støttet i 2025 her

Få et overordnet indblik i de nyeste tal og tendenser inden for kræft i Danmark. Læs Kræft i tal 2025 her

Venlig hilsen

Louise Elberg Pedersen
ForskningskoordinatorKræftens Bekæmpelse
Strandboulevarden 49
2100 København Ø
Telefon: +45 35 25 77 57

Orientering om ibrugtagning af patientkort til multipel sklerose patienter i B-celle-depleterende behandling

Dansk Multipel Sklerose Gruppe (DMSG) ønsker hermed at orientere om ibrugtagning af vedhæftede patientkort målrettet sundhedspersoner, som møder patienter med multipel sklerose i behandling med B-celle-depleterende præparater.

Patientkort_B-celle-depleterende_behandling_kreditkort_110626_noflip Patientkort_B-celle-depleterende_behandling_kreditkort_110626_flip

Patientkort_B-celle-depleterende_behandling_kreditkort_110626_noflip

Initiativet til patientkortet er taget på baggrund af en tiltagende hyppighed af sjældne og atypiske bivirkninger hos denne patientgruppe (i Danmark er der ca. 4500 multipel sklerose patienter i behandling med B-celle-depleterende behandlinger). Der er herudover gjort flere erfaringer med betydelig forsinkelse i diagnostik og behandling, blandt andet som følge af atypisk klinisk præsentation.

Patientkortet har til formål at understøtte tidligere genkendelse og korrekt håndtering af potentielt alvorlige komplikationer – også uden for neurologisk regi. Kortet fremhæver særligt:

  • Øget risiko for bakterielle, virale og svampeinfektioner samt late-onset neutropeni
  • Forekomst af atypiske infektioner, herunder neoehrlichiose, atypisk borreliose samt langvarige virusinfektioner
  • At antistofbaseret diagnostik ofte er falsk negativ, og at PCR-baseret diagnostik ofte bør overvejes
  • Forekomst af slimhindeinflammation (fx colitis, cystitis, konjunktivitis), som kan være behandlingsrelateret
  • Særlige behandlingsmæssige overvejelser ved udvalgte infektioner (fx doxycyklin, antiviral behandling, IVIG)

Patientkortet er udarbejdet i regi af DMSG og har været kommenteret af speciallæger i infektionsmedicin samt repræsentanter fra patientforening.

Vi håber, at I vil bidrage til at udbrede kendskabet til kortet blandt relevante faggrupper.

Hvis der er spørgsmål eller behov for yderligere information, er I meget velkomne til at kontakte os.

Med venlig hilsen

Finn Sellebjerg og Jeppe Romme Christensen, på vegne af Dansk Multipel Sklerose Gruppe (DMSG)

Jeppe Romme Christensen (MD PhD)
Danish Multiple Sclerosis Center

Department of Neurology

Rigshospitalet Glostrup

1 2 … 13
nNBV
nNBV